Prestige Brands (PBH) Beats Q3 Earnings and Revenue Estimates

12:15pm, Thursday, 03'rd Feb 2022 Zacks Investment Research
Prestige Brands (PBH) delivered earnings and revenue surprises of 11.24% and 5.57%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results

11:00am, Thursday, 03'rd Feb 2022 GlobeNewswire Inc.
TARRYTOWN, N.Y., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter ended December 31, 2021.
TARRYTOWN, N.Y., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter ended December 31, 2021.
Prestige Brands (PBH) delivered earnings and revenue surprises of 11.24% and 5.57%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Factors to Know Ahead of Prestige Consumer (PBH) Q3 Earnings

07:23pm, Tuesday, 01'st Feb 2022 Zacks Investment Research
Gains from brand-building strategies, e-commerce operations and buyouts might contribute to Prestige Consumer's (PBH) third-quarter fiscal 2022 results.
Gains from brand-building strategies, e-commerce operations and buyouts might contribute to Prestige Consumer's (PBH) third-quarter fiscal 2022 results.

Prestige Brands (PBH) Reports Next Week: Wall Street Expects Earnings Growth

08:01pm, Thursday, 27'th Jan 2022 Zacks Investment Research
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TARRYTOWN, N.Y., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 third quarter earnings release on Thursday, Februar
Prestige Consumer Healthcare Inc (PBH) shares closed today at 1.1% below its 52 week high of $63.83, giving the company a market cap of $3B. The stock is currently up 79.2% year-to-date, up 77.6% over the past 12 months, and up 20.3% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 57.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 434.2% The company's stock price performance over the past 12 months beats the peer average by 402.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -20.4% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Prestige Consumer Healthcare Inc (PBH) shares closed today at 1.9% below its 52 week high of $63.83, giving the company a market cap of $3B. The stock is currently up 75.1% year-to-date, up 74.9% over the past 12 months, and up 24.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 rose 0.3%. Trading Activity Trading volume this week was 32.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 455.2% The company's stock price performance over the past 12 months beats the peer average by 471.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -20.6% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Should Value Investors Consider Prestige (PBH) Stock Now?

07:13pm, Tuesday, 21'st Dec 2021 Zacks Investment Research
Let's see if Prestige (PBH) stock is a good choice for value-oriented investors right now from multiple angles.
Let's see if Prestige (PBH) stock is a good choice for value-oriented investors right now from multiple angles.
Equities analysts forecast that Prestige Consumer Healthcare Inc. (NYSE:PBH) will announce $259.99 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have provided estimates for Prestige Consumer Healthcares earnings. The lowest sales estimate is $259.50 million and the highest is $260.48 million. Prestige Consumer Healthcare reported sales of $238.79 million []
Strs Ohio purchased a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 24,000 shares of the companys stock, valued at approximately $1,346,000. Other hedge funds have also modified their holdings of the company. Eagle Bay Advisors []
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE